Skip to main content
Top
Published in: Addiction Science & Clinical Practice 1/2021

Open Access 01-12-2021 | Opioids | Commentary

Conceptualizing the effects of the COVID-19 pandemic on people with opioid use disorder: an application of the social ecological model

Authors: Ethan Cowan, Maria R. Khan, Siri Shastry, E. Jennifer Edelman

Published in: Addiction Science & Clinical Practice | Issue 1/2021

Login to get access

Abstract

The COVID-19 pandemic has resulted in unparalleled societal disruption with wide ranging effects on individual liberties, the economy, and physical and mental health. While no social strata or population has been spared, the pandemic has posed unique and poorly characterized challenges for individuals with opioid use disorder (OUD). Given the pandemic’s broad effects, it is helpful to organize the risks posed to specific populations using theoretical models. These models can guide scientific inquiry, interventions, and public policy. Models also provide a visual image of the interplay of individual-, network-, community-, structural-, and pandemic-level factors that can lead to increased risks of infection and associated morbidity and mortality for individuals and populations. Such models are not unidirectional, in that actions of individuals, networks, communities and structural changes can also affect overall disease incidence and prevalence. In this commentary, we describe how the social ecological model (SEM) may be applied to describe the theoretical effects of the COVID-19 pandemic on individuals with opioid use disorder (OUD). This model can provide a necessary framework to systematically guide time-sensitive research and implementation of individual-, community-, and policy-level interventions to mitigate the impact of the COVID-19 pandemic on individuals with OUD.
Literature
1.
go back to reference Baral S, Logie CH, Grosso A, Wirtz AL, Beyrer C. Modified social ecological model: a tool to guide the assessment of the risks and risk contexts of HIV epidemics. BMC Public Health. 2013;13:482.CrossRef Baral S, Logie CH, Grosso A, Wirtz AL, Beyrer C. Modified social ecological model: a tool to guide the assessment of the risks and risk contexts of HIV epidemics. BMC Public Health. 2013;13:482.CrossRef
2.
go back to reference Galea S, Vlahov D. Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. Public Health Rep. 2002;117(Suppl 1):S135-145.PubMedPubMedCentral Galea S, Vlahov D. Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. Public Health Rep. 2002;117(Suppl 1):S135-145.PubMedPubMedCentral
4.
go back to reference Schimmel J, Manini AF. Opioid use disorder and COVID-19: biological plausibility for worsened outcomes. Subst Use Misuse. 2020;55(11):1900–1.CrossRef Schimmel J, Manini AF. Opioid use disorder and COVID-19: biological plausibility for worsened outcomes. Subst Use Misuse. 2020;55(11):1900–1.CrossRef
5.
go back to reference Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry 2020:1–0. Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry 2020:1–0.
6.
go back to reference World Drug Report 2020 (United Nations publication, Sales No. E.20.XI.6). World Drug Report 2020 (United Nations publication, Sales No. E.20.XI.6).
8.
go back to reference Hawks L, Woolhandler S, McCormick D. COVID-19 in Prisons and Jails in the United States. JAMA Intern Med. 2020;180:1041–2.CrossRef Hawks L, Woolhandler S, McCormick D. COVID-19 in Prisons and Jails in the United States. JAMA Intern Med. 2020;180:1041–2.CrossRef
9.
go back to reference Leppla IE, Gross MS. Optimizing medication treatment of opioid use disorder during COVID-19 (SARS-CoV-2). J Addict Med. 2020;14(4):e1–3.CrossRef Leppla IE, Gross MS. Optimizing medication treatment of opioid use disorder during COVID-19 (SARS-CoV-2). J Addict Med. 2020;14(4):e1–3.CrossRef
10.
go back to reference Felsen UR, Fishbein DA, Litwin AH. Low rates of hepatitis A and B vaccination in patients with chronic hepatitis C at an urban methadone maintenance program. J Addict Dis. 2010;29(4):461–5.CrossRef Felsen UR, Fishbein DA, Litwin AH. Low rates of hepatitis A and B vaccination in patients with chronic hepatitis C at an urban methadone maintenance program. J Addict Dis. 2010;29(4):461–5.CrossRef
Metadata
Title
Conceptualizing the effects of the COVID-19 pandemic on people with opioid use disorder: an application of the social ecological model
Authors
Ethan Cowan
Maria R. Khan
Siri Shastry
E. Jennifer Edelman
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Addiction Science & Clinical Practice / Issue 1/2021
Electronic ISSN: 1940-0640
DOI
https://doi.org/10.1186/s13722-020-00210-w

Other articles of this Issue 1/2021

Addiction Science & Clinical Practice 1/2021 Go to the issue